Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
Working hard 'no longer enough to afford to buy a home'
Treasury writes off £340,000 in benefits overpayments in three years
Manxman to return to service following repairs
Discussions ongoing over meningitis B vaccine rollout
Health minister apologises for confusion over ambulance centre funding